Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.790
0.000
(0.00%)
At close: February 21 at 3:59:52 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-308,627
-323,664
-331,050
-245,143
-103,425
Investing Cash Flow
-163,762
-75,768
-324,568
683,521
-955,483
Financing Cash Flow
52,221
99,294
76,230
1,658,515
973,687
End Cash Position
1,254,561
1,461,623
1,716,351
2,128,429
65,096
Capital Expenditure
-81,313
-95,267
-238,552
-94,492
-175,955
Issuance of Capital Stock
--
1,853
1,250
1,743,334
970,113
Issuance of Debt
104,282
120,821
93,811
689
10,000
Repayment of Debt
-39,136
-8,744
-9,600
-400
--
Free Cash Flow
-389,940
-418,931
-569,602
-339,635
-279,380
12/31/2020 - 4/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2566.HK Hangzhou Jiuyuan Gene
7.160
+1.27%
9966.HK Alphamab Oncology
4.400
+5.77%
9969.HK InnoCare Pharma Limited
7.560
+2.86%
6821.HK Asymchem Laboratories (Tianjin) Co., Ltd.
60.150
+1.69%
2157.HK Lepu Biopharma Co., Ltd.
3.420
+4.59%
2616.HK CStone Pharmaceuticals
3.110
+4.71%
BSLNz.XC
2256.HK Abbisko Cayman Limited
6.500
+2.52%
0775.HK CKLIFE SCIENCES
0.520
0.00%
1548.HK GENSCRIPT BIO
13.220
+6.44%